The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage

被引:51
作者
Beyersdorf, Friedhelm [1 ]
机构
[1] Univ Freiburg, Dept Cardiovasc Surg, D-79106 Freiburg, Germany
关键词
Reperfusion; Ischaemia-reperfusion; Cardiac surgery; Controlled reperfusion; CONTROLLED LIMB REPERFUSION; ACUTE REGIONAL ISCHEMIA; LEUKOCYTE-DEPLETED REPERFUSION; TRANSPLANTED HUMAN HEARTS; SKELETAL-MUSCLE; MYOCARDIAL REPERFUSION; CARDIOPULMONARY BYPASS; BLOOD CARDIOPLEGIA; SURGICAL REVASCULARIZATION; CORONARY ANGIOPLASTY;
D O I
10.1093/cvr/cvp110
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Ischaemia and reperfusion occur during almost every cardiac operation, and one of the key elements to achieve a successful operation is to counteract the detrimental effects of induced ischaemia and reperfusion during the operation. The cardiac surgeon is in a unique position to protect the heart before ischaemia is induced and to avoid further damage during the reperfusion period. The surgeon can alter the composition of the reperfusate and the conditions of reperfusion so that the ischaemia/reperfusion injury is minimal, even after very complex procedures that require long aortic cross-clamp periods. This in turn allows him to perform a near-perfect surgical repair of the underlying disease without the pressure of time. The vast knowledge gained in this field over the years has led to application in other organs, such as the limbs (acute limb ischaemia), lungs (lung transplantation), kidney and liver (kidney and liver transplantation), and more recently even for the brain [acute cerebral artery occlusion (stroke)] and the whole body (cardiopulmonary resuscitation). Further improvements in reperfusion strategies will allow salvage of tissue and even whole body after ischaemic periods thought previously to be irreversibly damaged.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 79 条
[1]
ALLEN BS, 1986, J THORAC CARDIOV SUR, V92, P621
[2]
ALLEN BS, 1986, J THORAC CARDIOV SUR, V92, P594
[3]
ALLEN BS, 1986, J THORAC CARDIOV SUR, V92, P543
[4]
ALLEN BS, 1986, J THORAC CARDIOV SUR, V92, P564
[5]
ALLEN BS, 1993, J THORAC CARDIOV SUR, V105, P864
[6]
Allen BS, 1998, J CARDIAC SURG, V13, P224
[7]
ALLEN BS, 1986, J THORAC CARDIOV SUR, V92, P605
[8]
EVIDENCE FOR A REVERSIBLE OXYGEN RADICAL MEDIATED COMPONENT OF REPERFUSION INJURY - REDUCTION BY RECOMBINANT HUMAN SUPEROXIDE-DISMUTASE ADMINISTERED AT THE TIME OF REFLOW [J].
AMBROSIO, G ;
WEISFELDT, ML ;
JACOBUS, WE ;
FLAHERTY, JT .
CIRCULATION, 1987, 75 (01) :282-291
[9]
SUSTAINED BENEFIT OF TEMPORARY LIMITED REPERFUSION IN SKELETAL-MUSCLE FOLLOWING ISCHEMIA [J].
ANDERSON, RJ ;
CAMBRIA, R ;
KERR, J ;
HOBSON, RW .
JOURNAL OF SURGICAL RESEARCH, 1990, 49 (03) :271-275
[10]
[Anonymous], CARDIAC SURG